Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
Interstitial Cystitis, Painful Bladder Syndrome, Painful Bladder Syndrome (PBS)
About this trial
This is an interventional treatment trial for Interstitial Cystitis focused on measuring interstitial cystitis, painful bladder syndrome
Eligibility Criteria
Inclusion Criteria: Patients 18 years of age or older Female English Speaking Diagnosis of IC/PBS Have failed at least one prior treatment for IC/PBS Exclusion Criteria: Patients less than 18 years of age Unable to provide consent Non-English speaking Patients with known anatomical malformations of the ureters, bladder, or urethra
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Amniotic Membrane Therapy
Placebo
Under general anesthesia, cystoscopy will be performed. A needle will be inserted into the detrusor muscle to a depth of approximately 2 mm. 100mg of commercially available micronized amniotic membrane (Clarix Flo; BioTissue, Miami, FL) diluted in 10 mL of 0.9% preservative-free sodium chloride, and 0.5 mL of the solution will be injected into 20 equally spaced sites into the posterior and lateral walls of the bladder, sparing the dome and the trigone.
Under general anesthesia, cystoscopy will be performed. A needle will be inserted into the detrusor muscle to a depth of approximately 2 mm. 0.5 mL of 10 mL of 0.9% preservative-free sodium chloride will be injected into 20 equally spaced sites into the posterior and lateral walls of the bladder, sparing the dome and the trigone.